VITASPRING BIOMEDICAL CO., LTD.: 10-Q filed 2018-08-15

Name: VITASPRING BIOMEDICAL CO., LTD.: 10-Q filed 2018-08-15
Creator: VITASPRING BIOMEDICAL CO., LTD.

What VITASPRING BIOMEDICAL CO., LTD. reported in its quarterly report filed 2018-08-15 (fiscal Q2 2019): 24 published measures, 61 facts as tagged in accession 0001697884-18-000013.

This filing

Form: 10-Q (quarterly report)
Filed: 2018-08-15
Fiscal period: fiscal Q2 2019
Accession: 0001697884-18-000013 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All VITASPRING BIOMEDICAL CO., LTD. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2018-07-31	1,649	USD
At 2018-01-31	1,874	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2018-07-31	11,264	USD
At 2018-01-31	12,891	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2018-07-31	-7,587	USD
At 2018-01-31	-3,419	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit	Days
At 2018-07-31	537	USD
At 2018-01-31	5,207	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2018-05-01 to 2018-07-31	-11,969	USD	92
2018-02-01 to 2018-07-31	-6,990	USD	181
2017-05-01 to 2017-07-31	-1,168	USD	92
2017-02-01 to 2017-07-31	-2,269	USD	181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2018-02-01 to 2018-07-31	-17,591	USD	181
2017-02-01 to 2017-07-31	-3,865	USD	181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2018-05-01 to 2018-07-31	2,000	USD	92
2018-02-01 to 2018-07-31	14,450	USD	181
2017-05-01 to 2017-07-31	5,000	USD	92
2017-02-01 to 2017-07-31	11,120	USD	181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2018-02-01 to 2018-07-31	12,921	USD	181
2017-02-01 to 2017-07-31	6,500	USD	181

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2018-05-01 to 2018-07-31	3,087,686	shares	92
2018-02-01 to 2018-07-31	3,102,739	shares	181
2017-05-01 to 2017-07-31	300,000	shares	92
2017-02-01 to 2017-07-31	3,000,000	shares	181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2018-07-31	1,649	USD
At 2018-01-31	1,874	USD

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2018-07-31	9,615	USD
At 2018-01-31	11,017	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2018-07-31	18,851	USD
At 2018-01-31	16,310	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2018-07-31	651	USD
At 2018-01-31	1,410	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2018-05-01 to 2018-07-31	13,557	USD	92
2018-02-01 to 2018-07-31	18,309	USD	181
2017-05-01 to 2017-07-31	3,122	USD	92
2017-02-01 to 2017-07-31	9,375	USD	181

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2018-05-01 to 2018-07-31	1,588	USD	92
2018-02-01 to 2018-07-31	11,319	USD	181
2017-05-01 to 2017-07-31	1,954	USD	92
2017-02-01 to 2017-07-31	7,106	USD	181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2018-07-31	3,098,167	shares
At 2018-01-31	3,000,000	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2018-07-31	2,723	USD
At 2018-01-31	0	USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

Period	Value	Unit	Days
At 2018-07-31	0	USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2018-05-01 to 2018-07-31	-11,969	USD	92
2018-02-01 to 2018-07-31	-6,990	USD	181
2017-05-01 to 2017-07-31	-1,168	USD	92
2017-02-01 to 2017-07-31	-2,269	USD	181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2018-05-01 to 2018-07-31	13,557	USD	92
2018-02-01 to 2018-07-31	18,309	USD	181
2017-05-01 to 2017-07-31	3,122	USD	92
2017-02-01 to 2017-07-31	9,375	USD	181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2018-02-01 to 2018-07-31	225	USD	181
2017-02-01 to 2017-07-31	149	USD	181

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

Period	Value	Unit	Days
2018-02-01 to 2018-07-31	0	USD	181
2017-02-01 to 2017-07-31	0	USD	181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2018-02-01 to 2018-07-31	2,821	USD	181
2017-02-01 to 2017-07-31	0	USD	181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2018-02-01 to 2018-07-31	-759	USD	181
2017-02-01 to 2017-07-31	940	USD	181

Inspect the source

Entity: VITASPRING BIOMEDICAL CO., LTD. / CIK 0001697884
Captured: 2026-09-21T17:23:44.772Z
SEC response SHA-256: ee15de6dda3aedafc6c6b7ee7d9d21edb5e0091bf01dcbaec55b3fe460e6f43a

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001697884.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))